Attention Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office is Investigating Claims on Your BehalfNovember 20, 2025 1:55 PM EST | Source: Grabar Law OfficePhiladelphia, Pennsylvania--(Newsfile Corp. - November 20, 2025) - Grabar Law Office is investigating claims on behalf of Inspire Medical Systems, Inc. (NYSE: INSP) shareholders. The investigation concerns whether certain officers of Inspire Medical have breached their fiduciary duties owed to the company.Curr ...

Core Viewpoint - Varonis Systems, Inc. reported disappointing financial results for Q3 2025, leading to a significant decline in stock price and prompting an investigation into potential violations of federal securities laws [2][1]. Financial Performance - Varonis reported a revenue miss against consensus estimates, with a notable 63.9% year-over-year decline in term license subscription revenues [2]. - The company reduced its full-year Annual Recurring Revenue (ARR) guidance due to underperformance in its on-premises subscription business, which was identified as a drag on overall ARR growth [2]. Stock Market Reaction - Following the announcement of poor financial results, Varonis' stock price plummeted by $30.66 per share, or 48.67%, closing at $32.34 per share on October 29, 2025 [2]. Investigation - Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws on behalf of Varonis investors [1].

Accessibility StatementSkip Navigation NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zions Bancorporation, N.A. ("Zions" or the "Company") (NASDAQ: ZION). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Zions and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. CONTACT:Danielle PeytonPomerantz ...

Accessibility StatementSkip Navigation NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bitdeer Technologies Group ("Bitdeer" or the "Company") (NASDAQ: BTDR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Bitdeer and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information abo ...

Accessibility StatementSkip Navigation NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alkami Technology, Inc. ("Alkami" or the "Company") (NASDAQ: ALKT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Alkami and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about j ...

Accessibility StatementSkip Navigation NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. Also from this source On this news, Regencell's stock price fell $3.09 per share, or 18.56%, to close at $13.56 per share on November 3, 2025. Pomerantz LLP, with offices in New ...

Accessibility StatementSkip Navigation NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Beyond Meat, Inc. ("Beyond Meat" or the "Company") (NASDAQ: BYND).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Beyond Meat and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information a ...

NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet" or the "Company") (NYSE: ZBH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Zimmer Biomet and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. Accessibility StatementSkip Navigation [Click here for inf ...

Accessibility StatementSkip Navigation NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens Corning ("Owens Corning" or the "Company") (NYSE: OC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Owens Corning and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about j ...

Core Insights - Varonis Systems, Inc. is under investigation for potential securities fraud and unlawful business practices following disappointing financial results [1][2] Financial Performance - On October 28, 2025, Varonis reported third-quarter financial results that missed consensus estimates, including a significant 63.9% year-over-year decline in term license subscription revenues [2] - The company reduced its full-year Annual Recurring Revenue (ARR) guidance due to underperformance in its on-premises subscription business [2] - CEO Yakov Faitelson indicated that the on-premises subscription business is negatively impacting overall company ARR growth, citing lower renewal rates and sales process issues as contributing factors [2] Stock Market Reaction - Following the announcement of the financial results, Varonis's stock price dropped by $30.66 per share, or 48.67%, closing at $32.34 per share on October 29, 2025 [2]